Cytokine levels associated with favorable clinical outcome in the CAPSID randomized trial of convalescent plasma in patients with severe COVID-19

OBJECTIVES: To determine the profile of cytokines in patients with severe COVID-19 who were enrolled in a trial of COVID-19 convalescent plasma (CCP). METHODS: Patients were randomized to receive standard treatment and 3 CCP units or standard treatment alone (CAPSID trial, ClinicalTrials.gov NCT0443...

Descripción completa

Detalles Bibliográficos
Autores principales: Körper, Sixten, Schrezenmeier, Eva Vanessa, Rincon-Arevalo, Hector, Grüner, Beate, Zickler, Daniel, Weiss, Manfred, Wiesmann, Thomas, Zacharowski, Kai, Kalbhenn, Johannes, Bentz, Martin, Dollinger, Matthias M., Paul, Gregor, Lepper, Philipp M., Ernst, Lucas, Wulf, Hinnerk, Zinn, Sebastian, Appl, Thomas, Jahrsdörfer, Bernd, Rojewski, Markus, Lotfi, Ramin, Dörner, Thomas, Jungwirth, Bettina, Seifried, Erhard, Fürst, Daniel, Schrezenmeier, Hubert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582990/
https://www.ncbi.nlm.nih.gov/pubmed/36275695
http://dx.doi.org/10.3389/fimmu.2022.1008438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582990/
https://www.ncbi.nlm.nih.gov/pubmed/36275695
http://dx.doi.org/10.3389/fimmu.2022.1008438

Ejemplares similares